Product Information Compound Name CJC 1295 (No DAC) and Ipamorelin Net Content 10 mg total peptide content Composition CJC 1295 (No DAC) 5 mg Ipamorelin 5 mg Purity Greater than 99 percent (HPLC verified) Form Lyophilized peptide blend Storage Store unreconstituted material at ?20C for long term stability
All vials are sealed, lab-grade, and handled in accordance with proper cold-chain storage protocols during fulfillment
mTOR signaling controls the recruitment and activation of innate, acquired immune cells and fibroblast-like synoviocytes (FLSs) during RA, resulting in the production of numerous chemokines, pro-inflammatory cytokines, and cathepsin to degrade extracellular matrix and cartilage, further contributing to the early characteristics of synovitis [3, 54] (Fig
10.4161/psb.23136 26 EltayebA
Research suggests a TB-500 dose of 2-5mg administered twice weekly for four to eight weeks